More from GlaxoSmithKline
23andMe and GSK Are Using DNA to Develop New Drugs
A partnership between the two companies has yielded six potential new drugs, but using customers’ genetic information to do so raises ethical questions.
Jul 29th, 2019
Brexit Contingency Plans for Pharma Industry
The EU currently supplies two-thirds of the medicines in the UK. How will Brexit affect pharmaceutical investments and manufacturing?
Feb 28th, 2019
New Vaccine Fights Latent TB Infections
GlaxoSmithKline has developed a tuberculosis vaccine that could prevent the development of the bacterial disease in half of the recipients.
Oct 3rd, 2018
Dow Packaging's 2018 Awards for Packaging Innovation—Gold and Silver
The following are the 2018 Gold and Silver award winners.
Sep 14th, 2018
GSK Teams Up With 23andMe to Develop Drugs
GlaxoSmithKline has signed an agreement with home DNA test company 23andMe to collaborate on drug development.
Aug 3rd, 2018
GSK Recalls 600,000 Ventolin Inhalers
A manufacturing glitch at GSK’s North Carolina facility caused Ventolin inhalers to be made with a defective delivery system.
Apr 14th, 2017
Get to Know Trump’s FDA Pick
President Trump’s nominee for FDA commissioner, Scott Gottlieb, could help speed up regulatory approval of drugs.
Mar 21st, 2017
NICE Endorses GSK’s Asthma Biologic
GlaxoSmithKline’s biologic for severe refractory eosinophilic asthma receives approval from cost regulators.
Feb 2nd, 2017
GSK Label Mistakes Athlete’s Foot with Jock Itch
Labeling issues stating “use for the cure of most jock itch' rather than 'use for the cure of most athlete's foot' leads to massive recall.
Dec 16th, 2016